Sustained Release Therapies with the Prostaglandin Analogues Intracameral Implants

Autor:	Abdelrahman M. Elhusseiny, Ahmad A. Aref
Jazyk:	angličtina
Rok vydání:	2024
Předmět:	Travoprost Implant Intraocular IOP Sustained release Glaucoma Ophthalmology RE1-994
Zdroj:	Ophthalmology and Therapy, Vol 13, Iss 7, Pp 1833-1839 (2024)
Druh dokumentu:	article
ISSN:	2193-8245 2193-6528
DOI:	10.1007/s40123-024-00965-4
Popis:	Abstract The travoprost intracameral implant was recently approved by the US Food and Drug Administration for sustained release medical treatment of open-angle glaucoma in the USA. The approval represents a substantial and progressive step forward in the area of sustained-release glaucoma therapy. Topical intraocular pressure-lowering medications for the treatment of glaucoma are faced with a host of challenges for long-term and usually lifelong care. A changing paradigm in glaucoma management involves first-line interventions with laser modalities, micro-invasive surgeries, and sustained-release treatment platforms. Future needs in the area of sustained-release therapy include a non-prostaglandin drug delivery platform and longer-term treatments that do not require surgical reintervention.
Databáze:	Directory of Open Access Journals
Externí odkaz:	https://doaj.org/article/e4c2f0c1ae154e36a434f05d7da8d98d Zobrazit plný text záznamu View record in DOAJ Plný text ve formátu PDF Plný text ve formátu HTML
Nepřihlášeným uživatelům se plný text nezobrazuje	K zobrazení výsledku je třeba se přihlásit.